{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:18:22Z","timestamp":1793657902952,"version":"4.5.1"},"reference-count":374,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2012,1,25]],"date-time":"2012-01-25T00:00:00Z","timestamp":1327449600000},"content-version":"vor","delay-in-days":8789,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[1988,1,2]]},"abstract":"<jats:p>Ciprofloxacin, considered a benchmark when comparing new fluoroquinolones, shares with these agents a common mechanism of action: inhibition of DNA gyrase. While ciprofloxacin demonstrated a fairly good activity against gram\u2010positive bacteria, it is against gram\u2010negative organisms that it proved to be more potent than other fluoroquinolones. It is the most active quinolone against <jats:italic>Pseudomonas aeruginosa<\/jats:italic>, with MIC<jats:sub>90<\/jats:sub>s on the order of 0.5 \u03bcg\/ml. When given orally, ciprofloxacin exhibited 70% bioavailability and attained peak serum levels ranging between 1.5 and 2.9 \u03bcg\/ml after a single 500\u2010mg dose. Nineteen percent of an oral dose was excreted as metabolites in both urine and feces. In most cases, body fluids and tissue concentrations equaled or exceeded those in concurrent serum samples. In clinical trials, oral and intravenous ciprofloxacin yielded similar clinical and bacteriologic results compared to standard therapy in a wide array of systemic infections, including lower and upper urinary tract infections; gonococcal urethritis; skin, skin structure, and bone infections; and respiratory tract and gastrointestinal tract infections. Major benefits with the oral form of this quinolone are expected in chronic pyelonephritis and bone infections, and in pulmonary exacerbations in patients with cystic fibrosis. Emergence of ciprofloxacin\u2010resistant microorganisms has been noted in clinical practice, primarily <jats:italic>Pseudomonas aeruginosa<\/jats:italic> and <jats:italic>Staphylococcus aureus<\/jats:italic>. The most frequent side effects are related to the gastrointestinal tract; but attention should be given to adverse central nervous system effects.<\/jats:p>","DOI":"10.1002\/j.1875-9114.1988.tb04058.x","type":"journal-article","created":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T14:04:30Z","timestamp":1450274670000},"page":"3-30","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":235,"title":["Ciprofloxacin: Chemistry, Mechanism of Action, Resistance, Antimicrobial Spectrum, Pharmacokinetics, Clinical Trials, and Adverse Reactions"],"prefix":"10.1002","volume":"8","author":[{"given":"Marc","family":"LeBel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,1,25]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196611172752001"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1976.03270170023019"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.25.3.319"},{"key":"e_1_2_1_5_2","first-page":"75","article-title":"Recent advances in pharmaceutical chemistry: the 4\u2010quinolone antibiotics","volume":"11","author":"Jack DB","year":"1986","journal-title":"J Clin Hosp Pharm"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/16.6.805-a"},{"key":"e_1_2_1_7_2","first-page":"299","article-title":"Awakening the slumbering potential of the 4\u2010quinolone antibacterials","volume":"233","author":"Smith JT","year":"1984","journal-title":"Pharm J"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jac\/18.Supplement_D.21","article-title":"The mode of action of 4\u2010quinolones and possible mechanisms of resistance","volume":"18","author":"Smith JT","year":"1986","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"e_1_2_1_9_2","first-page":"12","article-title":"Mechanisms of action of and resistance to ciprofloxacin","volume":"82","author":"Hooper DC","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.2.307"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00153a015"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01977492"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.26.6.797"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1159\/000238309"},{"key":"e_1_2_1_15_2","first-page":"411","volume-title":"Drug resistance in bacteria","author":"Inoue S"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/13.suppl_B.9"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.25.6.775"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1159\/000238311"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/19.3.404"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/153.3.617"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1159\/000238494"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.25.5.633"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.29.1.40"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02001575"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.29.4.675"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/154.2.349"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.25.3.331"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.24.4.568"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.26.6.933"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02013582"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/18.2.163"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.29.5.852"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.24.2.302"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.29.6.1098"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.27.5.688"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.29.2.325"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/17.3.287"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.23.4.559"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/14.2.191"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02148670"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/17.2.155"},{"key":"e_1_2_1_42_2","first-page":"317","article-title":"Comparative in vitro studies with 4\u2010quinolone antimicrobials","volume":"11","author":"Felmingham D","year":"1985","journal-title":"Drug Exp Clin Res"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365548509070426"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/13.4.333"},{"issue":"4","key":"e_1_2_1_45_2","first-page":"33","article-title":"In vitro activity of ciprofloxacin against gram\u2010positive bacteria. An overview","volume":"82","author":"Kayser FH","year":"1987","journal-title":"Am J Med"},{"issue":"4","key":"e_1_2_1_46_2","first-page":"27","article-title":"In vitro activity of ciprofloxacin against gram\u2010positive cocci","volume":"82","author":"Barry AL","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.30.6.940"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/18.6.768"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/17.3.281"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/13.4.325"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01977499"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01977488"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/17.suppl_B.1"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01977489"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01641358"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.30.2.330"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/15.6.679"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/18.6.675"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/15.4.457"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365548609032321"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.26.5.785"},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.30.4.574"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/18.6.693"},{"key":"e_1_2_1_64_2","unstructured":"ScribnerRK MuszynskiMJ MarksMl.In vitro activity of antimicrobials alone or in combination against Pseudomonas cepacia. Presented at the 24th interscience conference on antimicrobial agents and chemotherapy Washington DC October 1984."},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/17.5.605"},{"key":"e_1_2_1_66_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.3.430"},{"key":"e_1_2_1_67_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.27.1.76"},{"key":"e_1_2_1_68_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/16.5.575"},{"key":"e_1_2_1_69_2","doi-asserted-by":"crossref","unstructured":"HeifetsL.Bacteriostatic and bactericidal activity of ofloxacin and ciprofloxacin against M. tuberculosis and M. avium. Presented at the annual meeting of the American Society For Microbiology Atlanta March 1987.","DOI":"10.1016\/0041-3879(87)90067-5"},{"key":"e_1_2_1_70_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/18.2.251"},{"key":"e_1_2_1_71_2","first-page":"13","article-title":"Activity of quinolones against Legionella","volume":"2","author":"Meyer R","year":"1986","journal-title":"Quinolones Bull"},{"key":"e_1_2_1_72_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.29.3.386"},{"issue":"4","key":"e_1_2_1_73_2","first-page":"23","article-title":"Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria","volume":"82","author":"Young LS","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/0732-8893(87)90077-0"},{"key":"e_1_2_1_75_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/19.5.605"},{"key":"e_1_2_1_76_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/19.5.617"},{"issue":"4","key":"e_1_2_1_77_2","first-page":"2","article-title":"Overview of preclinical studies with ciprofloxacin","volume":"82","author":"Sanders CC","year":"1987","journal-title":"Am J Med"},{"issue":"4","key":"e_1_2_1_78_2","first-page":"376","article-title":"In vitro study with ciprofloxacin: interpretive criteria of agar diffusion test according to standards of the NCCLS and DIN","volume":"82","author":"Grimm H","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_79_2","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1128\/jcm.21.6.880-883.1985","article-title":"Ciprofloxacin disk susceptibility tests: interpretive zone size standards for 5\u2010\u03bcg disks","volume":"21","author":"Barry AL","year":"1985","journal-title":"J Clin Microbiol"},{"key":"e_1_2_1_80_2","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1128\/jcm.24.3.448-450.1986","article-title":"Tentative disk diffusion susceptibility interpretive criteria for perfloxacin","volume":"24","author":"Fuchs PC","year":"1986","journal-title":"J Clin Microbiol"},{"key":"e_1_2_1_81_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.23.1.86"},{"key":"e_1_2_1_82_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.25.3.342"},{"key":"e_1_2_1_83_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.28.4.524"},{"key":"e_1_2_1_84_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.29.5.927"},{"issue":"2","key":"e_1_2_1_85_2","first-page":"1","article-title":"The effects of cations upon the activity of quinolone agents","volume":"1","author":"Neu HC","year":"1985","journal-title":"Quinolones Bull"},{"key":"e_1_2_1_86_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/16.3.341"},{"issue":"4","key":"e_1_2_1_87_2","first-page":"58","article-title":"Post\u2010antibiotic suppressive effect of ciprofloxacin against gram\u2010positive and gram\u2010negative bacteria","volume":"82","author":"Chin N\u2010X","year":"1987","journal-title":"Am J Med"},{"issue":"4","key":"e_1_2_1_88_2","first-page":"395","article-title":"Ciprofloxacin: an overview and prospective appraisal","volume":"82","author":"Neu HC","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_89_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/140.4.639"},{"key":"e_1_2_1_90_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.28.5.663"},{"key":"e_1_2_1_91_2","unstructured":"DudleyMN BlaserJ KuepkerM GilbertD MayerKH ZinnerSH.Synergism between ciprofloxacin and azlocillin against Pseudomonas aeruginosa in an in vitro model: effect of simultaneous versus \u201cstaggered\u201d administration. Presented at the 26th interscience conference on antimicrobial agents and chemotherapy New Orleans October 1986."},{"key":"e_1_2_1_92_2","first-page":"226","article-title":"Comprehensive evaluation of ciprofloxacin in combination with \u03b2\u2010lactam antibiotics against Enterobacteriaceae and Pseudomonas aeruginosa","volume":"36","author":"Haller I","year":"1986","journal-title":"Arzneimittelforsch"},{"key":"e_1_2_1_93_2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/jac\/18.Supplement_D.49","article-title":"Bactericidal activity of ciprofloxacin alone and in combination with azlocillin in an in vitro capillary model","volume":"18","author":"Zinner SH","year":"1986","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"e_1_2_1_94_2","first-page":"849","article-title":"Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods","volume":"82","author":"Moody JA","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_95_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/16.6.713"},{"key":"e_1_2_1_96_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/18.6.770"},{"key":"e_1_2_1_97_2","doi-asserted-by":"publisher","DOI":"10.1159\/000238493"},{"key":"e_1_2_1_98_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.6.959"},{"key":"e_1_2_1_99_2","unstructured":"BustamanteCI WhartonRC SabaGP WadeJC.Activity of aztreonam in combination with ciprofloxacin and rifampin against Pseudomonas aeruginosa. Presented at the annual meeting of the American Society For Microbiology Atlanta Georgia March 1987."},{"key":"e_1_2_1_100_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.24.5.754"},{"key":"e_1_2_1_101_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.30.6.892"},{"key":"e_1_2_1_102_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.28.5.700"},{"key":"e_1_2_1_103_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/18.6.667"},{"issue":"4","key":"e_1_2_1_104_2","first-page":"21","article-title":"Brief reports: effects of ciprofloxacin on plasmids","volume":"82","author":"Weisser J","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_105_2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1128\/jb.131.1.76-81.1977","article-title":"R\u2010Plasmid transfer and its response to nalidixic acid","volume":"131","author":"Burman LG","year":"1977","journal-title":"J Bacteriol"},{"key":"e_1_2_1_106_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.10.5.779"},{"issue":"4","key":"e_1_2_1_107_2","first-page":"55","article-title":"Brief report: in vivo curing of plasmids from multi\u2010drug\u2010resistant Serratia marcescens by ciprofloxacin","volume":"82","author":"Mehtar S","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_108_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.4.531"},{"key":"e_1_2_1_109_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(00)84662-9"},{"key":"e_1_2_1_110_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.27.3.353"},{"key":"e_1_2_1_111_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.27.4.531"},{"key":"e_1_2_1_112_2","doi-asserted-by":"publisher","DOI":"10.1080\/01483918508067095"},{"key":"e_1_2_1_113_2","doi-asserted-by":"publisher","DOI":"10.1080\/01483918508067101"},{"key":"e_1_2_1_114_2","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/clinchem\/31.5.684","article-title":"Liquid\u2010chromatographic determination of ciprofloxacin in serum and urine","volume":"31","author":"Nix DE","year":"1985","journal-title":"Clin Chem"},{"key":"e_1_2_1_115_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.28.2.311"},{"key":"e_1_2_1_116_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01975486"},{"key":"e_1_2_1_117_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.30.2.325"},{"key":"e_1_2_1_118_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-198609000-00018"},{"key":"e_1_2_1_119_2","first-page":"325","article-title":"Liquid chromatographic determination of ciprofloxacin and some metabolites in human body fluids","volume":"24","author":"Borner K","year":"1986","journal-title":"J Clin Chem Biochem"},{"key":"e_1_2_1_120_2","doi-asserted-by":"publisher","DOI":"10.1080\/01483918608074158"},{"key":"e_1_2_1_121_2","first-page":"R10","article-title":"The analysis of quinolones and their metabolites by high pressure liquid chromatography","volume":"329","author":"Manoharan M","year":"1985","journal-title":"Arch Pharm"},{"key":"e_1_2_1_122_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(87)80504-2"},{"key":"e_1_2_1_123_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02075716"},{"key":"e_1_2_1_124_2","first-page":"131","article-title":"Antibacterial activity of the metabolites of ciprofloxacin and its significance in the bioassay","volume":"37","author":"Zeiler H\u2010J","year":"1987","journal-title":"Arzneimittelforsch"},{"key":"e_1_2_1_125_2","first-page":"1417","article-title":"Transfer of ciprofloxacin to bile and determination of biliary metabolites in humans","volume":"36","author":"Tanimura H","year":"1986","journal-title":"Arzneimittelforsch"},{"key":"e_1_2_1_126_2","first-page":"111","volume-title":"First international ciprofloxacin workshop, Leverkusen, FRG, 1985","author":"Bergan T","year":"1986"},{"issue":"4","key":"e_1_2_1_127_2","first-page":"97","article-title":"Pharmacokinetics of intravenous ciprofloxacin and increasing doses of oral ciprofloxacin","volume":"82","author":"Bergan T","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_128_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02013983"},{"key":"e_1_2_1_129_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01977494"},{"key":"e_1_2_1_130_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01977496"},{"key":"e_1_2_1_131_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1984.192"},{"key":"e_1_2_1_132_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.27.3.350"},{"key":"e_1_2_1_133_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.28.1.74"},{"key":"e_1_2_1_134_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.29.3.501"},{"key":"e_1_2_1_135_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02075709"},{"key":"e_1_2_1_136_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.30.3.444"},{"key":"e_1_2_1_137_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.6.956"},{"key":"e_1_2_1_138_2","first-page":"122","volume-title":"First international ciprofloxacin workshop, Leverkusen, FRG, 1985","author":"Forrest A","year":"1986"},{"key":"e_1_2_1_139_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.30.3.440"},{"key":"e_1_2_1_140_2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/jac\/18.Supplement_D.83","article-title":"Pharmacokinetics of ciprofloxacin in healthy volunteers and in patients with impaired kidney function","volume":"18","author":"Webb DB","year":"1986","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"e_1_2_1_141_2","first-page":"363","article-title":"Pharmacokinetics and pharmacodynamics of intravenous ciprofloxacin. Studies in in vivo and in an in vitro dynamic model","volume":"82","author":"Dudley MN","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_142_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.24.5.784"},{"key":"e_1_2_1_143_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.29.1.62"},{"key":"e_1_2_1_144_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.27.3.375"},{"key":"e_1_2_1_145_2","first-page":"136","volume-title":"First international ciprofloxacin workshop, Leverkusen, FRG, 1985","author":"Wingender W","year":"1986"},{"key":"e_1_2_1_146_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02013667"},{"key":"e_1_2_1_147_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)92596-1"},{"key":"e_1_2_1_148_2","first-page":"249","article-title":"Ciprofloxacin and antacids","volume":"2","author":"Fleming LW","year":"1986","journal-title":"Lancet"},{"key":"e_1_2_1_149_2","unstructured":"HoffkenG LodeH WileyP\u2010D et al.Pharmacokinetics and interaction in the bioavailability of new quinolones. Present at the first International symposium on new quinolones Geneva July 1986."},{"issue":"4","key":"e_1_2_1_150_2","first-page":"119","article-title":"Drug interactions of ciprofloxacin with other nonantibiotic agents","volume":"82","author":"Rubinstein E","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_151_2","first-page":"511","article-title":"Pharmacocin\u00e9tique de la ciprofloxacine dans l'insuffisance r\u00e9nale","volume":"4","author":"Taburet AM","year":"1985","journal-title":"J Pharm Clin"},{"key":"e_1_2_1_152_2","first-page":"141","volume-title":"First international ciprofloxacin workshop, Leverkusen, FRG, 1985","author":"Beermann D","year":"1986"},{"issue":"2","key":"e_1_2_1_153_2","first-page":"403","article-title":"Mechanism of renal excretion of ciprofloxacin (Bay 9867), a new quinolone carboxylinc acid derivative in humans","volume":"4","author":"Wingender W","year":"1985","journal-title":"Chemotherapy"},{"key":"e_1_2_1_154_2","first-page":"756","article-title":"Renale ausscheidung von ciprofloxacin und einigen metaboliten nach einmoliger oraler und intravenoser gabe von 50 mg","volume":"26","author":"Borner K","year":"1984","journal-title":"Fortschr Antimikrob Antineoplast Chemother"},{"key":"e_1_2_1_155_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1985.102"},{"key":"e_1_2_1_156_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.26.5.757"},{"key":"e_1_2_1_157_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.26.5.741"},{"key":"e_1_2_1_158_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02013985"},{"key":"e_1_2_1_159_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.29.2.298"},{"key":"e_1_2_1_160_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.28.2.235"},{"key":"e_1_2_1_161_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.26.2.208"},{"key":"e_1_2_1_162_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02013990"},{"key":"e_1_2_1_163_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01660419"},{"key":"e_1_2_1_164_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02013992"},{"key":"e_1_2_1_165_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/18.1.107"},{"key":"e_1_2_1_166_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.29.3.405"},{"key":"e_1_2_1_167_2","first-page":"197","volume-title":"First international ciprofloxacin workshop, Leverkusen, FRG, 1985","author":"Braun R","year":"1986"},{"key":"e_1_2_1_168_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01977495"},{"key":"e_1_2_1_169_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/14.6.641"},{"key":"e_1_2_1_170_2","doi-asserted-by":"publisher","DOI":"10.1159\/000238308"},{"key":"e_1_2_1_171_2","first-page":"166","volume-title":"First international ciprofloxacin workshop, Leverkusen, FRG, 1985","author":"Schalkhauser K","year":"1986"},{"key":"e_1_2_1_172_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02013991"},{"key":"e_1_2_1_173_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/17.4.544"},{"key":"e_1_2_1_174_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.30.1.88"},{"issue":"4","key":"e_1_2_1_175_2","first-page":"130","article-title":"Brief report: prostatic tissue concentrations of ciprofloxacin after oral administration","volume":"82","author":"Gombert ME","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_176_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01651152"},{"key":"e_1_2_1_177_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02013986"},{"key":"e_1_2_1_178_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.30.2.260"},{"key":"e_1_2_1_179_2","first-page":"153","volume-title":"First international ciprofloxacin workshop, Leverkusen, FRG, 1985","author":"Thys JP","year":"1986"},{"key":"e_1_2_1_180_2","unstructured":"Hoogkamp\u2010KorstanjeJAA KleinS.Ciprofloxacin in acute exacerbation of chronic bronchitis. Presented at the 14th international congress of chemotherapy Kyoto Japan June 1985."},{"key":"e_1_2_1_181_2","first-page":"685","article-title":"Ciprofloxacin bei mukorviszidose zystiche fibrose, eine pharmakokinetische untersuchung","volume":"3","author":"Shah PM","year":"1984","journal-title":"Fortschr Antimikrob Antineoplast Chemother"},{"key":"e_1_2_1_182_2","first-page":"53","article-title":"Penetration of ciprofloxacin into human lung tissue following intravenous injection","volume":"14","author":"Schienkhoff D","year":"1986","journal-title":"Infection"},{"key":"e_1_2_1_183_2","first-page":"204","volume-title":"First international ciprofloxacin workshop, Leverkusen, FRG, 1985","author":"Bassaris HP","year":"1986"},{"key":"e_1_2_1_184_2","first-page":"206","volume-title":"First international ciprofloxacin workshop, Leverkusen, FRG, 1985","author":"Kitzes\u2010Cohen R","year":"1986"},{"key":"e_1_2_1_185_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.6.899"},{"key":"e_1_2_1_186_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/3.1.45"},{"key":"e_1_2_1_187_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/18.5.644"},{"key":"e_1_2_1_188_2","unstructured":"NaberK SorgelF SchumackerH NauschI MahrG.Time penetration of quinolones into prostatic fluid of man determined by a new method. Presented at the 27th interscience conference on antimicrobial agents and chemotherapy New York October 1987."},{"key":"e_1_2_1_189_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)61919-0"},{"key":"e_1_2_1_190_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)92315-4"},{"key":"e_1_2_1_191_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02013988"},{"key":"e_1_2_1_192_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/17.4.535"},{"key":"e_1_2_1_193_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.26.3.289"},{"key":"e_1_2_1_194_2","first-page":"192","volume-title":"First international ciprofloxacin workshop, Leverkusen, FRG, 1985","author":"Luthy R","year":"1986"},{"key":"e_1_2_1_195_2","unstructured":"AdenisJP DenisF MolinierM.Ciprofloxacin levels in human eye after oral and intravenous administration. Presented at the 27th interscience conference on antimicrobial agents and chemotherapy New York October 1987."},{"key":"e_1_2_1_196_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/16.1.67"},{"key":"e_1_2_1_197_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.38.4.442"},{"key":"e_1_2_1_198_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/20.2.290"},{"key":"e_1_2_1_199_2","unstructured":"KowalskyS EcholsR McCormickE AndrewsE.Pharmacokinetics of ciprofloxacin in subjects with varying degrees of renal function and on hemodialysis and peritoneal dialysis. Presented at the 25th interscience conference on antimicrobial agents and chemotherapy Minneapolis October 1985."},{"key":"e_1_2_1_200_2","unstructured":"BerganT DalhoffA EngesetA OlszewskiW ThorteinssonSB.A review of the pharmacokinetics and tissue penetration of ciprofloxacin. In:DaikosGK MashimoK eds.Ciprofloxacin: antimicrobial activity pharmacokinetics and clinical evaluation. Proceedings of a workshop held at the 14th international congress on chemotherapy Kyoto Japan July 1985."},{"issue":"4","key":"e_1_2_1_201_2","first-page":"139","article-title":"Pharmacokinetic study of ciprofloxacin in patients with impaired renal function","volume":"82","author":"Gasser TC","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_202_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.6.860"},{"key":"e_1_2_1_203_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.30.1.152"},{"key":"e_1_2_1_204_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01975477"},{"key":"e_1_2_1_205_2","first-page":"127","volume-title":"First international ciprofloxacin workshop, Leverkusen, FRG, 1985","author":"Danielson BG","year":"1986"},{"key":"e_1_2_1_206_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/16.1.87"},{"key":"e_1_2_1_207_2","unstructured":"ForrestA DrusanoGL PlaisanceK KrollG GonzalesM.Effects of dose ranging and repeated doses on the pharmacokinetics of ciprofloxacin and its major metabolites. Presented at the third world conference on clinical pharmacology and therapeutics Stockholm July 1986."},{"key":"e_1_2_1_208_2","first-page":"167","article-title":"Pharmacokinetics of oral ciprofloxacin and metabolites in renal impairment [abstr]","volume":"41","author":"Lettieri J","year":"1987","journal-title":"Clin Pharmacother"},{"key":"e_1_2_1_209_2","first-page":"7","article-title":"Dose regimens of quinolones in reduced renal function","volume":"2","author":"Bergan T","year":"1986","journal-title":"Quinolones Bull"},{"key":"e_1_2_1_210_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1986.tb03458.x"},{"key":"e_1_2_1_211_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/17.5.629"},{"issue":"4","key":"e_1_2_1_212_2","first-page":"108","article-title":"Pharmacokinetics in the elderly population: studies with ciprofloxacin","volume":"82","author":"LeBel M","year":"1987","journal-title":"Am J Med"},{"issue":"4","key":"e_1_2_1_213_2","first-page":"124","article-title":"Pharmacokinetics of ciprofloxacin in acutely ill and convalescent elderly patients","volume":"82","author":"Guay DRP","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_214_2","unstructured":"LettieriJ FrostRW KrolG LasseterK ShomblenEC.Effects of cirrhosis on ciprofloxacin pharmacokinetics. Presented at the 27th interscience conference on antimicrobial agents and chemotherapy New York October 1987."},{"key":"e_1_2_1_215_2","unstructured":"DrusanoG ForrestA PlaisanceK et al.Ciprofloxacin hepatic handling. Presented at the 27th interscience conference on antimicrobial agents and chemotherapy New York October 1987."},{"key":"e_1_2_1_216_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01644804"},{"key":"e_1_2_1_217_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1986.tb02938.x"},{"issue":"4","key":"e_1_2_1_218_2","first-page":"189","article-title":"Pharmacokinetics of two dosage regimens of ciprofloxacin during a two\u2010week therapeutic trial in patients with cystic fibrosis","volume":"82","author":"Shalit I","year":"1987","journal-title":"Am J Med"},{"issue":"4","key":"e_1_2_1_219_2","first-page":"174","article-title":"Ciprofloxacin monotherapy for acute pulmonary exacerbations of cystic fibrosis","volume":"82","author":"Goldfarb J","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_220_2","unstructured":"SorgelF StephenU WiesemannHG et al.Ciprofloxacin and perfloxacin as model compound to test the rationality of high dose requirements of antibiotics in cystic fibrosis patients. Presented at the first international symposium on quinolones Geneva July 1986."},{"key":"e_1_2_1_221_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.6.915"},{"issue":"4","key":"e_1_2_1_222_2","first-page":"352","article-title":"Dual individualization of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections","volume":"82","author":"Nix DE","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_223_2","unstructured":"DudleyMN ZinnerSH.Simultaneous pharmacokinetics and pharmacodynamic modeling of the antipseudomonal activity of ciprofloxacin: importance of bacterial sub\u2010populations. Presented at the 27th interscience conference on antimicrobial agents and chemotherapy New York October 1987."},{"key":"e_1_2_1_224_2","unstructured":"PlaisanceK ForrestA DrusanoG StandifordH.Relationship between ciprofloxacin serum concentrations MICs and serum inhibitory titers. Presented at the 27th interscience conference on antimicrobial chemotherapy New York October 1987."},{"key":"e_1_2_1_225_2","first-page":"630","article-title":"Controversies in antimicrobial therapy: critical analysis of clinical trials","volume":"43","author":"Polk RE","year":"1986","journal-title":"Am J Hosp Pharm"},{"key":"e_1_2_1_226_2","first-page":"405","volume-title":"First international ciprofloxacin workshop, Leverkusen, FRG, 1985","author":"Heifer C","year":"1986"},{"issue":"4","key":"e_1_2_1_227_2","first-page":"369","article-title":"Treatment of serious infections with intravenous ciprofloxacin","volume":"82","author":"Scully BE","year":"1987","journal-title":"Am J Med"},{"issue":"4","key":"e_1_2_1_228_2","first-page":"346","article-title":"Use of intravenous ciprofloxacin in difficult\u2010to\u2010treat infections","volume":"82","author":"Giamarellou H","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_229_2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/jac\/18.Supplement_D.165","article-title":"Preliminary evaluation of ciprofloxacin, a new 4\u2010quinolone antibiotic, in the treatment of febrile neutropenic patients","volume":"18","author":"Smith GM","year":"1986","journal-title":"J Antimicrob Chemother"},{"key":"e_1_2_1_230_2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jac\/18.Supplement_D.175","article-title":"Intravenous ciprofloxacin in the treatment of infection in immunocompromised patients","volume":"18","author":"Wood ME","year":"1986","journal-title":"J Antimicrob Chemother"},{"key":"e_1_2_1_231_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02013996"},{"key":"e_1_2_1_232_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)90937-2"},{"key":"e_1_2_1_233_2","first-page":"414","volume-title":"First international ciprofloxacin workshop, Leverkusen, FRG, 1985","author":"Mehtar S","year":"1986"},{"key":"e_1_2_1_234_2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/jac\/18.Supplement_D.179","article-title":"Oral ciprofloxacin therapy of infection caused by multiply resistant bacteria other than Pseudomonas aeruginosa","volume":"18","author":"Scully BE","year":"1986","journal-title":"J Antimicrob Chemother"},{"key":"e_1_2_1_235_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.28.2.308"},{"issue":"4","key":"e_1_2_1_236_2","first-page":"233","article-title":"Clinical evaluation of ciprofloxacin in patients with moderately severe bacterial infections","volume":"82","author":"Berman SJ","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_237_2","unstructured":"ChanCC OppenheimBA AndersonH ScarffeJH.Randomised prospective trial comparing the efficacy of netilmicin and ciprofloxacin versus netilmicin and piperacillin as empirical therapy in febrile neutropenic patients. Presented at the 27th interscience conference on antimicrobial agents and chemotherapy New York October 1987."},{"key":"e_1_2_1_238_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-198307000-00010"},{"key":"e_1_2_1_239_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.161"},{"key":"e_1_2_1_240_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02017380"},{"key":"e_1_2_1_241_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/134.Supplement_1.S219"},{"key":"e_1_2_1_242_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1987.tb04030.x"},{"issue":"4","key":"e_1_2_1_243_2","first-page":"270","article-title":"New approaches to the treatment of urinary tract infections","volume":"82","author":"Tolkoff\u2010Rubin NE","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_244_2","first-page":"241","article-title":"Current therapy of urinary tract infections and pyelonephritis","volume":"6","author":"Lawrence RM","year":"1986","journal-title":"Semin Nephrol"},{"key":"e_1_2_1_245_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.1.1"},{"key":"e_1_2_1_246_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/9.Supplement_2.S195"},{"key":"e_1_2_1_247_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-106-3-467"},{"issue":"4","key":"e_1_2_1_248_2","first-page":"278","article-title":"Treatment of complicated urinary tract infections with ciprofloxacin","volume":"82","author":"Gasser TC","year":"1987","journal-title":"Am J Med"},{"issue":"4","key":"e_1_2_1_249_2","first-page":"381","article-title":"Ciprofloxacin: an update on clinical experience","volume":"82","author":"Arcieri G","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_250_2","first-page":"318","volume-title":"First international ciprofloxacin workshop, Leverkusen, FRG, 1986","author":"Naber K","year":"1986"},{"key":"e_1_2_1_251_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/16.2.211"},{"key":"e_1_2_1_252_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02014000"},{"key":"e_1_2_1_253_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02014002"},{"key":"e_1_2_1_254_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02014004"},{"key":"e_1_2_1_255_2","first-page":"300","volume-title":"First international ciprofloxacin workshop, Leverkusen, FRG, 1985","author":"Cassiers JP","year":"1986"},{"key":"e_1_2_1_256_2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/jac\/18.Supplement_D.117","article-title":"Ciprofloxacin therapy in complicated urinary tract infections caused by Pseudomonas aeruginosa and other resistant bacteria","volume":"18","author":"Leigh DA","year":"1986","journal-title":"J Antimicrob Chemother"},{"key":"e_1_2_1_257_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.2.148"},{"issue":"4","key":"e_1_2_1_258_2","first-page":"288","article-title":"Brief report: ciprofloxacin in the treatment of urinary tract infections caused by Pseudomonas species and organisms resistant to trimethoprim\/sulfamethoxazole","volume":"82","author":"Cox C","year":"1987","journal-title":"Am J Med"},{"issue":"4","key":"e_1_2_1_259_2","first-page":"295","article-title":"Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim\/sulfamethoxazole\u2010resistant bacteria","volume":"82","author":"Preheim LC","year":"1987","journal-title":"Am J Med"},{"issue":"4","key":"e_1_2_1_260_2","first-page":"303","article-title":"Oral ciprofloxacin in resistant urinary tract infections","volume":"82","author":"Ryan JL","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_261_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.2.354"},{"issue":"4","key":"e_1_2_1_262_2","first-page":"280","article-title":"Treatment of chronic bacterial prostatitis with ciprofloxacin: results of a one\u2010year follow\u2010up study","volume":"82","author":"Weidner W","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_263_2","unstructured":"ZamfirescuC ChyskyV.Clinical efficacy of ciprofloxacin in difficult\u2010to\u2010treat patients suffering from urinary tract infections and prostatitis. Presented at the 14th international congress on chemotherapy Kyoto Japan July 1985."},{"key":"e_1_2_1_264_2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/jac\/18.Supplement_D.111","article-title":"A comparative study of ciprofloxacin and trimethoprim in the treatment of urinary tract infections in geriatric patients","volume":"18","author":"Newsom SWB","year":"1986","journal-title":"J Antimicrob Chemother"},{"key":"e_1_2_1_265_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02014003"},{"issue":"4","key":"e_1_2_1_266_2","first-page":"284","article-title":"Ciprofloxacin versus cinoxacin in therapy of urinary tract infections: a randomized, double\u2010blind trial","volume":"82","author":"Goldstein EJC","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_267_2","first-page":"314","volume-title":"First international ciprofloxacin workshop, Leverkusen, FRG, 1985","author":"Naber KG","year":"1986"},{"key":"e_1_2_1_268_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01661301"},{"key":"e_1_2_1_269_2","unstructured":"BelliL CastroJM CascoR.Ciprofloxacin in the treatment of noncomplicated gonococcal urethritis. Presented at the 14th international congress on chemotherapy Kyoto Japan July 1985."},{"key":"e_1_2_1_270_2","first-page":"302","article-title":"Single dose ciprofloxacin for treating gonococcal infections in men","volume":"61","author":"Loo PS","year":"1985","journal-title":"Genitourinary Med"},{"key":"e_1_2_1_271_2","first-page":"86","article-title":"Ciprofloxacin for treating urethral gonorrhoea in men","volume":"62","author":"Shahmanesh M","year":"1986","journal-title":"Genitourinary Med"},{"key":"e_1_2_1_272_2","first-page":"60","article-title":"Quinolones in the treatment of gonorrhoea and Chlamydia trachomatis infections","volume":"8","author":"Stolz E","year":"1986","journal-title":"Pharm Weekbl [Sci]"},{"key":"e_1_2_1_273_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.30.2.267"},{"key":"e_1_2_1_274_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/18.Supplement_D.129"},{"issue":"4","key":"e_1_2_1_275_2","first-page":"311","article-title":"Treatment of nongonococcal urethritis with ciprofloxacin","volume":"82","author":"Fong IW","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_276_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01661307"},{"key":"e_1_2_1_277_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.30.4.590"},{"key":"e_1_2_1_278_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02013994"},{"issue":"4","key":"e_1_2_1_279_2","first-page":"224","article-title":"Therapy of skin and skin structure infections with ciprofloxacin \u2014 an overview","volume":"82","author":"Eron LJ","year":"1987","journal-title":"Am J Med"},{"issue":"4","key":"e_1_2_1_280_2","first-page":"266","article-title":"Randomized trial of ciprofloxacin compared with other antimicrobial therapy in the treatment of osteomyelitis","volume":"82","author":"Greenberg RN","year":"1987","journal-title":"Am J Med"},{"issue":"4","key":"e_1_2_1_281_2","first-page":"154","article-title":"Acute bacterial exacerbations in bronchitis and asthma","volume":"82","author":"Chodosh S","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_282_2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/jac\/18.Supplement_D.133","article-title":"Efficacy and safety of ciprofloxacin in patients with respiratory infections in comparison with amoxycillin","volume":"18","author":"Gleadhill IC","year":"1986","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"e_1_2_1_283_2","first-page":"208","article-title":"Low\u2010dose ciprofloxacin in respiratory tract infections: a randomized comparison with doxycycline in general practice","volume":"82","author":"Bantz PM","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_284_2","first-page":"260","volume-title":"First international ciprofloxacin workshop, Leverkusen, FRG, 1985","author":"Magnani C","year":"1986"},{"key":"e_1_2_1_285_2","first-page":"265","volume-title":"First international ciprofloxacin workshop, Leverkusen, FRG, 1985","author":"Feist H","year":"1986"},{"key":"e_1_2_1_286_2","first-page":"270","volume-title":"First international ciprofloxacin workshop, Leverkusen, FRG, 1985","author":"Chodosh S","year":"1986"},{"key":"e_1_2_1_287_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01975481"},{"key":"e_1_2_1_288_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/18.3.296"},{"key":"e_1_2_1_289_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.29.6.1088"},{"issue":"4","key":"e_1_2_1_290_2","first-page":"357","article-title":"Use of intravenous ciprofloxacin in respiratory tract infections and biliary sepsis","author":"Chrysanthopoulos CJ","year":"1987","journal-title":"Am J Med"},{"issue":"4","key":"e_1_2_1_291_2","first-page":"169","article-title":"Clinical efficacy of ciprofloxacin in the treatment of patients with respiratory tract infections in Japan","volume":"82","author":"Kobayashi H","year":"1987","journal-title":"Am J Med"},{"issue":"4","key":"e_1_2_1_292_2","first-page":"202","article-title":"Efficacy and safety of oral ciprofloxacin in the treatment of serious respiratory infections","volume":"82","author":"Fass RJ","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_293_2","volume-title":"First international ciprofloxacin workshop, Leverkusen, FRG, 1985","author":"DuBois RM","year":"1986"},{"key":"e_1_2_1_294_2","first-page":"272","volume-title":"First International Ciprofloxacin Workshop, FRG, 1985","author":"Bender SW","year":"1986"},{"key":"e_1_2_1_295_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)91374-7"},{"issue":"4","key":"e_1_2_1_296_2","first-page":"189","article-title":"Randomized study of two dosage regimens of ciprofloxacin for treating chronic bronchopulmonary infection in patients with cystic fibrosis","volume":"82","author":"Shalit I","year":"1987","journal-title":"Am J Med"},{"issue":"4","key":"e_1_2_1_297_2","first-page":"196","article-title":"Ciprofloxacin therapy in cystic fibrosis","volume":"82","author":"Scully BE","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_298_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)90062-6"},{"issue":"4","key":"e_1_2_1_299_2","first-page":"180","article-title":"Ciprofloxacin versus tobramycin plus azlocillin in pulmonary exacerbations in adult patients with cystic fibrosis","volume":"82","author":"Bosso JA","year":"1987","journal-title":"Am J Med"},{"issue":"4","key":"e_1_2_1_300_2","first-page":"185","article-title":"Ciprofloxacin: comparative data in cystic fibrosis","volume":"82","author":"Rubio TT","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_301_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01645207"},{"issue":"4","key":"e_1_2_1_302_2","first-page":"329","article-title":"Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea","volume":"82","author":"Pichler HET","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_303_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-106-2-216"},{"key":"e_1_2_1_304_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.28.1.128"},{"key":"e_1_2_1_305_2","first-page":"353","volume-title":"First international ciprofloxacin workshop, Leverkusen, FRG, 1985","author":"Schonwald S","year":"1986"},{"key":"e_1_2_1_306_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1068678"},{"key":"e_1_2_1_307_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01645442"},{"key":"e_1_2_1_308_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/16.5.667"},{"key":"e_1_2_1_309_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/18.5.647"},{"key":"e_1_2_1_310_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)91649-6"},{"key":"e_1_2_1_311_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02014006"},{"issue":"4","key":"e_1_2_1_312_2","first-page":"324","article-title":"Current problems in the non\u2010fluid treatment of bacterial enteric infection","volume":"82","author":"DuPont HL","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_313_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/152.1.104"},{"key":"e_1_2_1_314_2","first-page":"433","volume-title":"First international ciprofloxacin workshop, Leverkusen, FRG, 1985","author":"Hellriegel KP","year":"1986"},{"key":"e_1_2_1_315_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-106-1-7"},{"key":"e_1_2_1_316_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01645437"},{"key":"e_1_2_1_317_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.29.2.298"},{"key":"e_1_2_1_318_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02013987"},{"key":"e_1_2_1_319_2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/jac\/18.Supplement_D.89","article-title":"The effect of quinolone antibacterials on the gastrointestinal flora compared with that of other antibacterials","volume":"18","author":"Reeves DS","year":"1986","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"e_1_2_1_320_2","first-page":"333","article-title":"Influence of oral ciprofloxacin or ofloxacin on the fecal flora of healthy volunteers","volume":"82","author":"Shah PM","year":"1987","journal-title":"Am J Med"},{"issue":"4","key":"e_1_2_1_321_2","first-page":"336","article-title":"Effect of ciprofloxacin on fecal flora of patients with cystic fibrosis and other patients treated with oral ciprofloxacin","volume":"82","author":"Scully BE","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_322_2","first-page":"67","article-title":"Quinolones and colonization resistance in human volunteers","volume":"8","author":"Saene JJM","year":"1986","journal-title":"Pharm Week Sci Edit"},{"key":"e_1_2_1_323_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-106-1-144"},{"key":"e_1_2_1_324_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/17.4.535"},{"key":"e_1_2_1_325_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)91242-0"},{"key":"e_1_2_1_326_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.6.962"},{"key":"e_1_2_1_327_2","unstructured":"PugsleyMP DworzackDL RaccaforteJS SandersCC SandersWEJr.An open study of the efficacy and safety of ciprofloxacin in eliminating the chronic nasopharyngeal carriage of Neisseria meningitidis. Presented at the 27th interscience conference antimicrobial agents and chemotherapy New York October 1987."},{"key":"e_1_2_1_328_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)92343-8"},{"key":"e_1_2_1_329_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)90083-2"},{"key":"e_1_2_1_330_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)92511-5"},{"key":"e_1_2_1_331_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)91862-8"},{"key":"e_1_2_1_332_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)90880-3"},{"key":"e_1_2_1_333_2","unstructured":"FreiR BindschedlerM FollathF StalderH ReberH.Emergence of resistance to ciprofloxacin during therapy. Presented at the first international symposium on quinolones Geneva July 1986."},{"key":"e_1_2_1_334_2","unstructured":"SchachtP HullmannR.Is development of resistance during ciprofloxacin therapy a clinical problem?Presented at the 15th international congress on chemotherapy Istanbul Turkey July 1987."},{"key":"e_1_2_1_335_2","unstructured":"Pech\u00e8reJC Michea\u2010HamzenhpourM AuckenthalerR RegaweyP.Ways for limiting emergence of resistance during quinolone therapy of experimental Pseudomonas aeruginosa infection. Presented at the 27th interscience conference on antimicrobial agents and chemotherapy New York October 1987."},{"key":"e_1_2_1_336_2","unstructured":"PhilipsI.Comparative agents and antibiotic interactions. Presented at the first international symposium on quinolones Geneva July 1986."},{"key":"e_1_2_1_337_2","first-page":"448","volume-title":"First international ciprofloxacin workshop, Leverkusen, FRG, 1985","author":"Fass RJ","year":"1986"},{"key":"e_1_2_1_338_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/18.SD.187"},{"key":"e_1_2_1_339_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198530060-00003"},{"issue":"4","key":"e_1_2_1_340_2","first-page":"115","article-title":"Ciprofloxacin increases serum levels of theophylline","volume":"82","author":"Raoof S","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_341_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1986.tb02957.x"},{"key":"e_1_2_1_342_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/19.2.263"},{"issue":"4","key":"e_1_2_1_343_2","first-page":"215","article-title":"Ciprofloxacin for eradication of methicillin\u2010resistant Staphylococcus aureus colonization","volume":"82","author":"Mulligan ME","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_344_2","unstructured":"HoriS ShimadaJ SaitoA MiyaharaT KuriokaS MatsudaM.Effect of new quinolones on \u03b3\u2010aminobutyric acid receptor binding. Presented at the 25th interscience conference on antimicrobial agents and chemotherapy Minneapolis October 1985."},{"key":"e_1_2_1_345_2","first-page":"569","article-title":"Gyrase\u2010Haemmer: zentral\u2010nevrose nebenwirkungen","volume":"112","author":"Schnuch A","year":"1987","journal-title":"Dtsch Med Wochenschr"},{"key":"e_1_2_1_346_2","unstructured":"HoriS ShimadaJ SaitoA MiyahoraT KuriokaS MatsudaM.Inhibitory effect of quinolones on \u03b3\u2010aminobutyric acid receptor binding. Their structure activity relationship. Presented at the 26th interscience conference on antimicrobial agents and chemotherapy New Orleans October 1986."},{"key":"e_1_2_1_347_2","first-page":"24","article-title":"Quinolones: adverse drug reactions in FRG","volume":"1087","year":"1986","journal-title":"Script"},{"key":"e_1_2_1_348_2","unstructured":"RangoowolaR.Efficacy of ofloxacin in respiratory infections. New directions in antimicrobial agents. Presented at the 6th international symposium on the frontiers of pharmacotherapy Philadelphia May 2223 1986."},{"key":"e_1_2_1_349_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01646106"},{"key":"e_1_2_1_350_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01642807"},{"key":"e_1_2_1_351_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/18.Supplement_D.139"},{"key":"e_1_2_1_352_2","doi-asserted-by":"publisher","DOI":"10.1159\/000238444"},{"key":"e_1_2_1_353_2","doi-asserted-by":"publisher","DOI":"10.1159\/000238534"},{"key":"e_1_2_1_354_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.23.2.284"},{"key":"e_1_2_1_355_2","volume-title":"Noroxin (norfloxacin) monograph","author":"Sharp Merck","year":"1986"},{"key":"e_1_2_1_356_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/19.6.709"},{"key":"e_1_2_1_357_2","first-page":"604","article-title":"Nalidixic acid arthralgia","volume":"107","author":"Barley RR","year":"1972","journal-title":"Can Med Assoc J"},{"key":"e_1_2_1_358_2","first-page":"590","article-title":"Norfloxacin\u2010induced rheumatic disease","volume":"96","author":"Bailey RR","year":"1983","journal-title":"NZ Med J"},{"key":"e_1_2_1_359_2","unstructured":"DesplacesN GuttmannL AcarJF.Twice daily and therapy for chronic staphylococcal osteitis with a new quinolone pefloxacin alone or in combination with rifampicin. Presented at the 24th interscience conference on antimicrobial agents and chemotherapy Washington DC October 1984."},{"key":"e_1_2_1_360_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4274(77)90016-9"},{"key":"e_1_2_1_361_2","doi-asserted-by":"publisher","DOI":"10.2131\/jts.3.357"},{"key":"e_1_2_1_362_2","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(79)90020-6"},{"key":"e_1_2_1_363_2","unstructured":"HowardLC VanSickleDC DeshnukhK GriffingWV OwenNV.Cinoxacin\u2010induced arthropathy in juvenile beagle dogs. Presented at the 18th annual meeting of the Society of Toxicology and Applied Pharmacology 1979."},{"key":"e_1_2_1_364_2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/030098588502200113","article-title":"Fine structural changes during reparative phase of canine drug\u2010induced arthropathy","volume":"22","author":"Cough AW","year":"1985","journal-title":"Vet Pathol"},{"issue":"4","key":"e_1_2_1_365_2","first-page":"91","article-title":"Ciprofloxacin: review of potential toxicologic effects","volume":"82","author":"Schluter G","year":"1987","journal-title":"Am J Med"},{"key":"e_1_2_1_366_2","unstructured":"StahlmannR BlankenburgG NeubertD.Studies on cartilage formation and differentiation in limb bud culture in the presence of nalidixic acid ofloxacin and ciprofloxacin. Presented at the first international symposium on new quinolones Geneva July 1986."},{"key":"e_1_2_1_367_2","unstructured":"SchaadUB KruckoJ.Nalidixic acid (NA) in children: retrospective matched controlled study for cartilage toxicity. Presented at the 26th interscience conference on antimicrobial agents and chemotherapy New Orleans October 1986."},{"key":"e_1_2_1_368_2","unstructured":"RumberW.Does nalidixic acid produce joint toxicity in childhood?Presented at the 15th international congress on chemotherapy Istanbul Turkey July 1987."},{"issue":"12","key":"e_1_2_1_369_2","first-page":"44","article-title":"Pathogenesis and management of arthroplasty in cystic fibrosis","volume":"79","author":"Phillips BM","year":"1986","journal-title":"J R Soc Med"},{"key":"e_1_2_1_370_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.295.6600.699"},{"key":"e_1_2_1_371_2","first-page":"193","article-title":"Gyrase Inhibitors Impair Caffeine elimination in men","volume":"9","author":"Staib AH","year":"1987","journal-title":"Meth Find Exptl Clin Pharmacol"},{"key":"e_1_2_1_372_2","unstructured":"HealyDP PolkR KanawatiL RockD MooneyM BuchA.Pharmacokinetic interaction between oral ciprofloxacin and caffeine in normal volunteers. Presented at the 27th interscience conference on antimicrobial agents and chemotherapy New York October 1987."},{"key":"e_1_2_1_373_2","unstructured":"SegevS RechavyM RubinsteinE.Quinolones theophylline and diclofenac interactions with the CNS GABA receptor. Presented at the 27th interscience conference on antimicrobial agents and chemotherapy New York October 1987."},{"key":"e_1_2_1_374_2","unstructured":"MorikawakK NagataO KuboS KotoH YamamotoK.Unusual CNS toxic action of new quinolones. Presented at the 27th interscience conference on antimicrobial agents and chemotherapy New York October 1987."},{"key":"e_1_2_1_375_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00637553"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1875-9114.1988.tb04058.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1875-9114.1988.tb04058.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1875-9114.1988.tb04058.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T16:29:29Z","timestamp":1761064169000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/j.1875-9114.1988.tb04058.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,1,2]]},"references-count":374,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1988,1,2]]}},"alternative-id":["10.1002\/j.1875-9114.1988.tb04058.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1875-9114.1988.tb04058.x","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,1,2]]},"assertion":[{"value":"2012-01-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}